Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Applied Genetic Technologies Corp (AGTC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12098
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pigmentosa, alpha-1 antitrypsin deficiency and macular degeneration, among others. AGTC’s achromatopsia provides treatment inherited conditions that are associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total loss of color discrimination. The company’s x-linked retinoschisis offers treatment in retinal degeneration affecting young males, presenting with poor vision by school age. It also offers ophthalmology development programs and proof-of-concept data in multiple indications. The company operates through its offices in Alachua and Cambridge, the US, and others. AGTC is headquartered in Alachua, Florida, the US.

Applied Genetic Technologies Corp (AGTC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Applied Genetic Technologies Corp, Medical Equipment, Deal Details 10
Partnerships 10
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 10
Equity Offering 11
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 11
Acquisition 13
Applied Genetic Acquires 5% Stake in Bionic Sight for USD2 Million 13
Applied Genetic Technologies Corp – Key Competitors 14
Applied Genetic Technologies Corp – Key Employees 15
Applied Genetic Technologies Corp – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Sep 10, 2018: AGTC announces financial results and business update for the fourth quarter and fiscal year ended June 30, 2018 17
May 08, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018 19
Feb 09, 2018: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017 21
Sep 13, 2017: AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017 23
May 10, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017 25
Feb 08, 2017: AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 28
Corporate Communications 30
Sep 24, 2018: AGTC names William Aliski to its board of directors 30
Jun 14, 2018: AGTC Announces Expansion of Clinical and Regulatory Leadership Teams 31
Feb 14, 2018: AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors 32
Sep 05, 2017: AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer 33
Aug 02, 2017: AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel 34
Product News 35
Aug 08, 2017: AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 16, 2017 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Applied Genetic Technologies Corp, Medical Equipment, Key Facts, 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Deals By Market, 2012 to YTD 2018 8
Applied Genetic Technologies Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 10
Applied Genetic Tech Plans to Raise up to USD125 Million in Public Offering of Securities 11
Applied Genetic Acquires 5% Stake in Bionic Sight for USD2 Million 13
Applied Genetic Technologies Corp, Key Competitors 14
Applied Genetic Technologies Corp, Key Employees 15

List of Figures
Applied Genetic Technologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Applied Genetic Technologies Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Applied Genetic Technologies Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Applied Genetic Technologies Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Applied Genetic Technologies Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Applied Genetic Technologies Corp (AGTC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Milestone Scientific Inc (MLSS)-医療機器分野:企業M&A・提携分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • General Mills Inc:戦略・SWOT・企業財務分析
    General Mills Inc - Strategy, SWOT and Corporate Finance Report Summary General Mills Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ConAgra Foods Inc:戦略・SWOT・企業財務分析
    ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report Summary ConAgra Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Muhibbah Engineering (M) Bhd:企業の戦略・SWOT・財務情報
    Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report Summary Muhibbah Engineering (M) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • National Institute on Drug Abuse:製薬・医療:M&Aディール及び事業提携情報
    Summary National Institute on Drug Abuse (NIDA), a subsidiary of National Institutes of Health is a research institute that provides drug abuse and addiction services. The institute offers services in drugs of abuse such as bath salts, cocaine, heroin, inhalants, alcohol, club drugs, methamphetamine …
  • Newmont Mining Corp:企業の戦略・SWOT・財務情報
    Newmont Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PZ Cormay SA (CRM):医療機器:M&Aディール及び事業提携情報
    Summary PZ Cormay SA (Cormay) is a medical device company that produces and wholesale diagnostic reagents and laboratory equipment. The company provides products such as reagents, analyzers, coagulation, electrophoresis, urinalysis, rapid tests, assay sheets, and blood control instruments and equipm …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Achelios Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Achelios Therapeutics Inc (Achelios) is a biopharmaceutical development company that provides reformulation of non-steroidal anti-inflammatory (NSAID) drug molecules. The company offers therapeutic entity development for the treatment of pain and inflammation. Its lead product includes Topof …
  • Papa John’s International, Inc.:戦略・SWOT・企業財務分析
    Papa John's International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Papa John's International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bank Hapoalim Bm
    Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Blockchain Power Trust (TEP.UN):電力:M&Aディール及び事業提携情報
    Summary Blockchain Power Trust is an alternative energy company that offers power solutions. The company's services include wind energy solutions, power generations, transmission, supplying, and distribution services. It also provides solar energy solutions, and hydropower energy solutions, among ot …
  • National Oilwell Varco Inc (NOV):企業の財務・戦略的SWOT分析
    National Oilwell Varco Inc (NOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kopitiam Investment Pte Ltd:企業の戦略・SWOT・財務分析
    Kopitiam Investment Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Kopitiam Investment Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Alexion Pharmaceuticals Inc (ALXN):企業の財務・戦略的SWOT分析
    Alexion Pharmaceuticals Inc (ALXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Black Hills Corporation (BKH)-石油・ガス分野:企業M&A・提携分析
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Unique Catering & Management Services Ltd:企業の戦略・SWOT・財務情報
    Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Biomay AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomay AG (Biomay) is a developer of therapeutics for allergy that discovers disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. It provides pipeline product portfolio such as investigation candidates targeted against IgE me …
  • JetBlue Airways Corp:企業の戦略・SWOT・財務分析
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆